Abstract
The overall prognosis of systemic lupus erythematosus (SLE) depends greatly on the severity of glomerular lesions. The introduction of corticosteroids followed by the use of alkylating agents has progressively increased the survival rate to 75% and even 90% in the last reported series.
This is a preview of subscription content, log in via an institution to check access.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1992 Sandoz Ltd, Basle and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Meyrier, A., Niaudet, P., Brodehl, J. (1992). Sandimmun in other etiologies of nephrotic syndrome. In: Optimal Use of Sandimmun® in Nephrotic Syndrome. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77310-5_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-77310-5_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-55180-5
Online ISBN: 978-3-642-77310-5
eBook Packages: Springer Book Archive